Corcept Therapeutics
$11.419876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.24 (-2.06%) As of 3:39 PM EDT today
-$0.24 (-2.06%) Today
Why Robinhood?
You can buy or sell CORT and other stocks, options, ETFs, and crypto commission-free!
About CORT
Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Read More Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Employees
206
Headquarters
Menlo Park, California
Founded
1998
Market Cap
1.32B
Price-Earnings Ratio
15.16
Dividend Yield
—
Average Volume
1.26M
High Today
$12.00
Low Today
$11.26
Open Price
$11.90
Volume
609.06K
52 Week High
$17.48
52 Week Low
$9.55
Collections
Analyst Ratings
50%
of 6 ratings
Buy
50%
Hold
33%
Sell
17%
CORT Earnings
$0.00
$0.11
$0.22
$0.33
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours